newsfilter
← Latest News
GlobeNewswire·

Adaptimmune to Report Q3 Financial Results and Business Update on Thursday, November 5, 2020

PHILADELPHIA and OXFORDSHIRE, U.K., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide...